In Q3 of last year, we commented on the risk that Delta-8 THC (∆8THC) presented hemp operators, and the industry at large. The immediate benefit to companies active in ∆8 markets was, and is, undeniable. The collapse of hemp prices – or hemp derivatives pricing – combined with COVID to brew a perfect storm for hemp entrepreneurs.
Current legislation for ∆8 is ambiguous, but it isn’t reasonable to expect the psychoactive substance to be unregulated in the open marketplace. In October of last year
Membership required to view content.
…
Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!